144 0001834021 XXXXXXXX LIVE 0001650648 4D Molecular Therapeutics, Inc. 001-39782 5858 Horton Street Suite 455 Emeryville CA 94608 1-510-505-2680 David Kirn Officer Class A Common Goldman Sachs & Co. LLC 200 West Street New York NY 10282 58333 802662.08 55244211 09/14/2026 NASD Class A Common 12/15/2020 Acquired from issuer in private transaction Issuer N 58333 12/15/2020 None N David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 08/03/2026 12415 124722.33 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 06/22/2026 114746 1200851.31 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 07/09/2026 42608 548177.48 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 07/10/2026 15725 189233.08 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 08/04/2026 26842 274596.34 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 08/19/2026 50000 799565 David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608 Class A Common 08/19/2026 19076 288707.63 The sales of shares set forth herein are made in connection with a selling plan dated 01/09/2026 that is intended to comply with Rule 10b5-1(c). 09/14/2026 01/09/2026 Goldman Sachs & Co. LLC on behalf of David Kirn